PhRMA Starts New Year With Familiar Drug Pricing Proposals Targeting The Supply Chain

 
• By Cathy Kelly
  
USPills
Rebate Reform, 340B Oversight On PhRMA's Agenda For 2020
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Pricing Debate

More from Market Access